EUVIMEDEUVIMED entdecken
Open Access

Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study

Yunro Chung iD, Tianxi Cai, Lisa Newcomb, Daniel W Lin, Yingye Zheng

Statistics in Medicine · 2025

DOI: 10.1002/sim.70072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Yunro Chung und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Solutions, Arizona State University, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Watchful Waiting. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When novel biomarkers are developed for the clinical management of patients diagnosed with cancer, it is critical to quantify the accuracy of a biomarker‐based decision tool. The evaluation can be challenging when the definite outcome , such as time to disease progression, is only partially ascertained on a limited set of study patients. Under settings where is only observed on a subset but an auxiliary outcome correlated with is available on all subjects, we propose an augmented estimation procedure for commonly used time‐dependent accuracy measures. The augmented estimators are easy to implement without imposing modeling assumptions between the two types of time‐to‐event outcomes and are more efficient than the complete‐case estimator. When the ascertainment of the outcome is non‐random and subject to informative censoring, we further augment our proposed method with inverse probability weighting to improve robustness. Results from simulation studies confirm the robustness and efficiency properties of the proposed estimators. The method is illustrated with data from the Canary Prostate Active Surveillance Study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorWatchful WaitingHumansMalePrognosisComputer SimulationDisease ProgressionModels, StatisticalProstate-Specific Antigen

Stichwörter der Autor:innen

informative censoringmissing datamis‐measured outcomeprognostic accuracyreceiver operating characteristics curvesurvival analysis

Substanzen

Biomarkers, TumorProstate-Specific Antigen

Autor:innen und Institutionen

  • College of Health Solutions, Arizona State University, Phoenix, AZ, USA.
  • Biodesign Center for Personalized Diagnostics, Arizona State University, Tempe, AZ, USA.
  • Department of Biostatistics, Harvard University, Boston, MA, USA.
  • Department of Urology, University of Washington, Seattle, WA, USA.
  • Department of Biostatistics, Fred Hutchinson Cancer Center, Seattle, WA, USA.

ORCID-Profile: Yunro Chung

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Chung, Y., Cai, T., Newcomb, L., Lin, D. W., & Zheng, Y. (2025). Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study. Statistics in Medicine. https://doi.org/10.1002/sim.70072

Vancouver

Chung Y, Cai T, Newcomb L, Lin DW, Zheng Y. Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study. Statistics in Medicine. 2025. doi:10.1002/sim.70072

BibTeX
@article{Chung2025,
  author = {Chung, Yunro and Cai, Tianxi and Newcomb, Lisa and Lin, Daniel W and Zheng, Yingye},
  title = {Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70072}
}
Kostenlos starten →